Equity
€86,954 ▲ 29.1%
PHARMACTION has made a profit without a break since 2019.
PHARMACTION
Lifetime
8 annual accounts with figures on one time axispeak €28,360 (2025)
€28,360▲ 26.2%
lowest -€3,383 (2018)
€19,582▲ 23.7%
peak €86,954 (2025)
€86,954▲ 29.1%
€203,918▼ 0.1%
Board2 names since 2017
2 directorsMarc PUISSANT BAEYENS and 1 other
Owners2 names in the annual accounts
30%PROFIELD
Documentsfilings and deeds
30-11-202562 days before the deadline
2025micro format
Gross margin from €22,478 to €28,360Equity from €67,373 to €86,954Cash from €29,904 to €5,916
Key points
from the 2025 annual accountsDebts
€203,918 70% of the balance sheet
Suppliers 92%Taxes and wages 4%Other 4%
At the same address
18 companies
Checked score
83
Excellent
Financially stronger than 42% of micro companies in advertising and market research (NACE 73)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.4% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: 0.2% across 11,228 companies (NACE 73, micro).
About 4 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.5%
01-2025: 0.6%▲ +0.1 percentage points vs 12-2024highest value
02-2025: 0.3%▼ -0.3 percentage points vs 01-2025
03-2025: 0.3%● unchanged vs 02-2025
04-2025: 0.3%● unchanged vs 03-2025
05-2025: 0.3%● unchanged vs 04-2025
06-2025: 0.3%● unchanged vs 05-2025
07-2025: 0.3%● unchanged vs 06-2025lowest value
08-2025: 0.3%● unchanged vs 07-2025lowest value
09-2025: 0.3%● unchanged vs 08-2025lowest value
10-2025: 0.3%● unchanged vs 09-2025
11-2025: 0.3%● unchanged vs 10-2025
12-2025: 0.3%● unchanged vs 11-2025
01-2026: 0.3%● unchanged vs 12-2025
02-2026: 0.3%● unchanged vs 01-2026
03-2026: 0.3%● unchanged vs 02-2026
04-2026: 0.3%● unchanged vs 03-2026
05-2026: 0.3%● unchanged vs 04-2026
06-2026: 0.3%● unchanged vs 05-2026
07-2026: 0.3%● unchanged vs 06-2026
08-2026: 0.3%● unchanged vs 07-2026
09-2026: 0.3%● unchanged vs 08-2026
10-2026: 0.4%▲ +0.1 percentage points vs 09-2026
11-2026: 0.4%● unchanged vs 10-2026
Financial strengthAverage
Score breakdown
raises risk
Liquidity: current ratio 1.42, cash €5,916, halved
lowers risk
Size: total assets €290,873
Sector: Advertising, market research and public relations activities (NACE 73)
Figures for financial year 2025 (filed on 05-12-2025)
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 73, micro). It does better than 34% of them on solvency, 9% on liquidity, 50% on profitability and 75% on growth.
The bankruptcy probability was computed on 08-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 30-06-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 6,713 companies had the same profile as PHARMACTION has now. Each dot stands for 17 companies, two years later.
95.8%
were still trading
2.2%
stopped another way
1.8%
went bankrupt
Another 0.2% stopped without a precise date, possibly only after those two years.
The bankruptcy probability of PHARMACTION itself is lower: 0.4% within 12 months. It rests on far more data about PHARMACTION than the profile alone.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 6,713 companies, not a prediction for PHARMACTION. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €7,000 on 30-day terms is acceptable
Liquidity is tight, with a current ratio of 1.42 (1.32 in 2024), below the usual 1.5. Short-term debt is 70.1% and cash 2% of total assets. 70.1% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 30-11-2025, 62 days ahead of the deadline.
NBB · 8 filingsDeviation from the deadline
2025
62 days early
2024
8 days early
2023
35 days early
2022
49 days early
2021
4 days early
2020
18 days late
2019
10 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 19 days before the deadline. In the sector (NACE 73), the median for financial year 2024 was 6 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-06-2026 is due by 31-01-2027. Nothing is late today. The company usually files around 27 December (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
30-06-2026 year end09-11-2026 today31-01-2027 deadline
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0671515855
Appointments: Marc PUISSANT BAEYENS (managing director) and Sébastien COLIN (managing director)
General meeting of 21-12-2023 · Gazette deed
Incorporation
published on 17-02-2017 · Gazette deed
First establishment
Berthelotstraat 106, Forest
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| PHARMACTION Forest | €290,873 | €28,360 | 29.9% | - |
| SMART.COM Couvin | €280,801 | €24,311 | 30.0% | - |
| Casa Blu Uccle | €301,545 | €27,139 | 38.5% | - |
| BD-EM Hamme (Vl.) | €260,989 | €38,858 | 66.3% | - |
| ContentMoon Antwerp | €284,583 | €19,303 | 10.1% | - |
| martijnknoops.be Oudsbergen | €231,758 | €37,773 | 53.9% | - |
| UW IDEE Tongeren-Borgloon | €356,022 | €35,891 | 25.1% | - |
These companies have the same main activity as PHARMACTION: advertising agencies (NACE 73110). They are comparable in size and age: total assets between €232,000 and €356,000, founded between 2013 and 2017.
Official details
Source: KBO- Status
- Active since 15-02-2017Normal situation
- Registered office
- 19 active companies are registered at this address3 started in the 12 months before. Source: KBO register, as of 9 November 2026.
- Activity
- Advertising agenciesNACE 73110and 1 other
- Establishment unit
- 2.262.617.8421190 Forest, since 15-02-2017
- Financial year end
- 30 June
- Peppol
- Reachable since 21-10-2026
Annual accounts to 30-06-2025
- ≈ €75,000estimated
- €290,873▲ 7.2%
- Filing
- Filed on 30-11-2025, 62 days before the end of the filing period
Insights on PHARMACTION
PHARMACTION files the micro format. That format states no turnover. The gross margin rose from €3,482 in 2018 to €28,360 in 2025.
In May 2024, the Official Gazette published the appointment of Marc PUISSANT BAEYENS as managing director.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about PHARMACTION
- What is the company number of PHARMACTION?
- The company number of PHARMACTION is 0671.515.855. The VAT number is the same number with BE in front: BE 0671.515.855.
- Where is PHARMACTION based?
- The registered office is at Berthelotstraat 106, 1190 Forest.Company details
- What does PHARMACTION do?
- According to the KBO register, the main activity is advertising agencies (NACE 73110).
- What is the legal form of PHARMACTION?
- PHARMACTION is a private limited company (BV).
- When was PHARMACTION founded?
- PHARMACTION was founded on 15-02-2017.
- Is PHARMACTION still active?
- Yes, PHARMACTION is an active enterprise in the KBO register.
- What is the turnover of PHARMACTION?
- The turnover in financial year 2025 is ≈ €75,000. This figure is estimated from the gross margin of €28,360 and 45 comparable companies (NACE 73). It probably lies between €53,000 and €100,000.Financials
- Is PHARMACTION profitable?
- In financial year 2025, PHARMACTION made a profit of €19,582.
- Where can I find the annual accounts of PHARMACTION?
- PHARMACTION filed 8 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of PHARMACTION due?
- PHARMACTION must file the annual accounts for financial year 2026 by 31-01-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.